The Cost-Benefit of Cholinesterase Inhibitors in Mild to Moderate Dementia: A Willingness-To-Pay Approach

Author： Wu G.   Lanctôt K.L.   Herrmann N.   Moosa S.   Oh P.I.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.17, Iss.14, 2003-01, pp. : 1045-1057

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluating Willingness-to-Pay Thresholds for Dementia Caregiving Interventions: Application to the Tailored Activity Program

By Jutkowitz Eric   Gitlin Laura N.   Pizzi Laura T.  

Value in Health, Vol. 13, Iss. 6, 2010-09 ,pp. : 720-725

Blackwell Publishing

Access to resources Recommend Favorite

Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer's Disease

By Green Colin   Picot Joanna   Loveman Emma   Takeda Andrea   Kirby Jo   Clegg Andrew  

PharmacoEconomics, Vol. 23, Iss. 12, 2005-01 ,pp. : 1271-1282

Adis International

Access to resources Recommend Favorite

Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer's Disease

By Bosanquet Nick  

PharmacoEconomics, Vol. 24, Iss. 6, 2006-01 ,pp. : 623-625

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Insulin Lispro versus Neutral (Regular) Insulin Therapy Using a Willingness-To-Pay Approach

By Davey P.  

PharmacoEconomics, Vol. 13, Iss. 3, 1998-03 ,pp. : 347-358

Adis International

Access to resources Recommend Favorite

The Economic Value of a New Insulin Preparation, Humalog Mix 25™: Measured by a Willingness-To-Pay Approach

By Dranitsaris G.  

PharmacoEconomics, Vol. 18, Iss. 3, 2000-09 ,pp. : 275-287

Adis International

Access to resources Recommend Favorite